Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
A registry for cohort members
Great Minds is a register of cohort study volunteers who are willing to participate in dementia trials

On Friday 25 January 2019, DPUK formally launched Great Minds – a specialist register for volunteers in dementia-focused clinical research. Great Minds brings together participants from population health studies and makes their extensive health data available to researchers looking to fast-track discoveries for new dementia treatments.

Working collaboratively with the Airwave Health Study – Imperial College’s population health study of members of the police force – Great Minds is running a pilot to establish the readiness of the Airwave participants to join Great Minds. Professor Paul Elliott, Principal Investigator of the Airwave study points out: "The biggest health problem the UK faces is dementia so we are delighted to partner with Great Minds to identify the causes of dementia and help develop new treatments."

We know that the causes of dementia start decades before symptoms show, and so the best people to help study these causes are healthy volunteers with background health information. Population health study participants are ideal, as they have provided background health data – sometimes going back years – as part of their original study.

Two million people in the UK have contributed to health studies, providing an amazing wealth of data including demographics, medical history, lifestyle, genetics, and test results. Great Minds aims to bring these people and their data together so that we can match them and their interests with clinical research aimed at accelerating the development of new dementia treatments.

We expect findings from the Great Minds pilot to be available in early March and anticipate that they will compare favourably to our estimate that 10% of participants will join Great Minds. With 38% of the UK population knowing a family member or close friend with dementia and 62% of people saying they would be willing to take part in dementia research, we dare hope that we may attract more to join Great Minds.

Similar stories

Comment: COVID has exposed the need for flexible global data access

At a time when the work of disease modellers has been thrust into the spotlight, DPUK’s director, Professor John Gallacher, comments on the important role of technology platforms which democratise access to global health data.

First participant arrives for screening as part of Deep and Frequent Phenotyping study

Researchers in Oxford have begun screening participants in DPUK’s Deep and Frequent Phenotyping (DFP) study – the world’s most detailed study into early Alzheimer’s disease.

Unlocking dementia with innovation

Applications are now open for data experts to apply to join the next DPUK datathons – highly focused ‘hackathon-style’ events at Swansea University and the University of East Anglia this autumn. Datathons bring data scientists of all backgrounds to the dementia challenge.

Data scientists’ opportunity to meet DPUK at ‘impactful AI’ event

Machine learning experts who may not have previous experience of working on dementia will have the chance to meet DPUK’s senior researcher at the first in a new series of events for data scientists. They’ll learn about opportunities to apply their skills and make a real impact on developing treatments for dementia.

Dementia Ecosystem UK: action through alliance

One in three people born today will develop dementia in their lifetime: it's the biggest health challenge of our generation. With one million people predicted to have dementia by 2025 in the UK, and a current cost of £26bn a year to the UK economy, there is huge financial and societal impact, yet we’re still without treatment.

Datathon series launch

Can you bring your advanced analytical skills in AI and machine learning to one of the world's biggest healthcare challenges?